Sitasar Trio 10mg/1000mg/100mg Tablet ER is an antidiabetic medicine used to treat Type II Diabetes. In type 2 diabetes, the pancreas does not produce enough insulin, or the body is unable to use insulin effectively. As a result, blood sugar levels become elevated.

Sitasar Trio 10mg/1000mg/100mg Tablet ER contains Dapagliflozin, Sitagliptin, and Metformin. It works by removing excess sugar from the body through urine, increasing the levels of certain natural substances that lower blood sugar when it is high, reducing sugar production by cells in the liver, and delaying sugar absorption from the intestines.

Take Sitasar Trio 10mg/1000mg/100mg Tablet ER as advised by your doctor. Sitasar Trio 10mg/1000mg/100mg Tablet ER may cause certain side effects such as vomiting, nausea, abdominal pain, headache and stomach upset. Most of these side effects do not need medical attention and resolve over time. If these side effects persist or worsen, please consult your doctor.

Do not take Sitasar Trio 10mg/1000mg/100mg Tablet ER if you are allergic to any of its components. Inform your doctor about your medical history and the medicines you are taking, including herbs and supplements, before starting the treatment with Sitasar Trio 10mg/1000mg/100mg Tablet ER. Let your doctor know if you are pregnant or breastfeeding before taking Sitasar Trio 10mg/1000mg/100mg Tablet ER. It is not recommended for use in children below 18 years of age.

• Take Sitasar Trio 10mg/1000mg/100mg Tablet ER with food to reduce stomach upset or gastrointestinal side effects.
• Follow your doctor's instructions on the dosage and timing of this medication to ensure safety.
• Swallow the medicine as a whole with a glass of water.
• Do not crush, break, or chew it.

• Sitasar Trio 10mg/1000mg/100mg Tablet ER is a combination of three antidiabetic medicines: Sitagliptin, Dapagliflozin, and Metformin, used in the management of Type 2 Diabetes Mellitus, along with proper diet and exercise.
• Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps increase insulin release and decrease glucagon levels in the body, lowering blood sugar levels when they are high.
• Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, works by removing excess glucose through the urine, thereby lowering blood sugar levels.
• Metformin is a biguanide which reduces the amount of sugar produced by the liver and delays glucose absorption from the intestine.
• It improves the body’s sensitivity to insulin, promoting better glucose uptake by muscles and tissues.
• The combined effect of these three drugs offers multi-targeted control of blood sugar levels, especially in patients not controlled by single or dual therapy.
• Sitasar Trio 10mg/1000mg/100mg Tablet ER helps manage blood glucose levels and prevents diabetes-related complications, such as eye problems, nerve problems, and kidney impairment.

• Sitasar Trio 10mg/1000mg/100mg Tablet ER should be avoided if you are allergic to any of the components in it.
• Before starting treatment, inform your doctor about your medical history and the medications you are taking, including any herbs and supplements. This can help prevent unwanted effects.
• Sitasar Trio 10mg/1000mg/100mg Tablet ER is not recommended for use in patients with severe liver or kidney disease.
• Consult your doctor if you are pregnant or breastfeeding.
• It is not recommended for use in children below 18 years of age.
• Avoid drinking alcohol while on Sitasar Trio 10mg/1000mg/100mg Tablet ER as it increases the risk of hypoglycemia and lactic acidosis (when the lactic acid increases in the body, which impacts the functioning of various organs in the body).